PDCD1 and neoplasm: Tumor-infiltrating lymphocytes (TILs) that express high levels of PD-1 are functionally impaired, failing to produce cytokines such as interleukin 2 (17–20), and the presence of intratumorally PD-1 signaling has been associated with worse survival in PDAC (21).